Hadassah Issues Statement in Response to District Court Decision in Texas Mifepristone Case

Monday, April 10, 2023

Media Contact
Lilly Freemyer


NEW YORK, NY – Hadassah National President Rhoda Smolow and Hadassah CEO Naomi Adler released the following statement today in response to the recent district court decision in Texas to repeal the approval of mifepristone:

"Judge Kacsmaryk’s decision to hold federal approval of mifepristone after years of safe use is an attack on American women and their right to health care, privacy and autonomy. Mifepristone has been safely used for over 20 years by millions of people in the US and across the world. Hadassah, The Women’s Zionist Organization of America, reaffirms its unwavering support for women’s right to full and complete access to reproductive health services and care. Hadassah will continue to fight for federal and state legislation affirming and protecting those rights."


Hadassah, The Women’s Zionist Organization of America, Inc. (HWZOA), is the largest Jewish women’s organization in the United States. With nearly 300,000 members, Associates and supporters, HWZOA brings women together to effect change and advocate on such critical issues as ensuring the security of Israel, combating antisemitism and promoting women’s health. Through the two hospitals of the Hadassah Medical Organization (HMO) in Jerusalem, HWZOA helps support both exemplary care for more than one million people every year and world-renowned medical research. HMO serves without regard to race, religion or nationality and earned a Nobel Peace Prize nomination in 2005 for building bridges to peace through medicine. Additionally, HWZOA supports several Youth Aliyah villages that set at-risk children in Israel on the path to a successful future. For more information, visit www.hadassah.org or follow Hadassah on Facebook, Instagram, LinkedIn and Twitter.